Stock Analysis on Net

Monsanto Co. (NYSE:MON)

This company has been moved to the archive! The financial data has not been updated since April 5, 2018.

Enterprise Value (EV) 

Microsoft Excel

Current Enterprise Value (EV)

Monsanto Co., current enterprise value calculation

Microsoft Excel
Current share price (P) $118.05
No. shares of common stock outstanding 441,283,987
US$ in millions
Common equity (market value)1 52,094
Add: Noncontrolling interest (per books) 20
Total equity 52,114
Add: Short-term debt, including current portion of long-term debt (per books) 870
Add: Long-term debt, excluding current portion (per books) 7,254
Total equity and debt 60,238
Less: Cash and cash equivalents 1,856
Less: Short-term investments 8
Enterprise value (EV) 58,374

Based on: 10-K (reporting date: 2017-08-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 118.05 × 441,283,987


Historical Enterprise Value (EV)

Monsanto Co., EV calculation

Microsoft Excel
Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014 Aug 31, 2013 Aug 31, 2012
Share price1, 2 $121.52 $102.49 $93.73 $112.18 $107.62 $88.69
No. shares of common stock outstanding1 440,199,969 437,982,595 439,837,164 484,073,332 525,837,818 534,598,091
US$ in millions
Common equity (market value)3 53,493 44,889 41,226 54,303 56,591 47,414
Add: Noncontrolling interest (book value) 20 11 15 39 169 203
Total equity 53,513 44,900 41,241 54,342 56,760 47,617
Add: Short-term debt, including current portion of long-term debt (book value) 870 1,587 615 233 51 36
Add: Long-term debt, excluding current portion (book value) 7,254 7,453 8,429 7,528 2,061 2,038
Total equity and debt 61,637 53,940 50,285 62,103 58,872 49,691
Less: Cash and cash equivalents 1,856 1,676 3,701 2,367 3,668 3,283
Less: Short-term investments 8 60 47 40 254 302
Enterprise value (EV) 59,773 52,204 46,537 59,696 54,950 46,106

Based on: 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31), 10-K (reporting date: 2013-08-31), 10-K (reporting date: 2012-08-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Monsanto Co. Annual Report.

3 2017 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 121.52 × 440,199,969


Common Equity (Market Value)
The common equity shows an overall increasing trend from 2012 to 2017, rising from 47,414 million US dollars in 2012 to 53,493 million US dollars in 2017. However, there is a notable dip in 2015 where the value decreased significantly to 41,226 million US dollars before recovering in subsequent years.
Total Equity
Total equity follows a pattern similar to common equity, starting at 47,617 million US dollars in 2012 and ending at 53,513 million US dollars in 2017. A substantial decline occurs in 2015, mirroring the dip observed in common equity, with total equity dropping to 41,241 million US dollars before increasing again in the following years.
Total Equity and Debt
The combined total of equity and debt demonstrates a general increase over the period, from 49,691 million US dollars in 2012 to 61,637 million US dollars in 2017. Unlike equity alone, this metric shows a steady rise except for a decrease in 2015, where the value fell to 50,285 million US dollars. Post-2015, there is a clear upward trend, suggesting growth in capital structure.
Enterprise Value (EV)
Enterprise value exhibits an overall positive trend from 2012 through 2017, growing from 46,106 million US dollars to 59,773 million US dollars. There is a decrease in 2015 to 46,537 million US dollars, correlating with the declines in equity and total capital. After 2015, enterprise value recovers and continues to rise, indicating enhanced valuation despite earlier dips.
Summary of Trends
The data indicates a consistent pattern across all key financial metrics with a pronounced downturn in 2015. Before 2015, there was steady growth in equity, combined capital, and enterprise value. The decline in 2015 may reflect operational, market, or structural challenges faced during that period. The recovery seen from 2016 onwards suggests a return to growth and improved financial health. Overall, the firm demonstrates resilience and an upward trajectory in market valuation and capital structure over the six-year period, notwithstanding the mid-cycle contraction.